Breaking News

The future of CRISPR, the biotech industry after the collapse of SVB, and the impact of CAR-T therapy

STAT

www.statnews.com

2023_STATBreakthrough_Summit_MarketingAssets_Email_General_V1-1

From the future of CRISPR to the biotech industry after the collapse of SVB

This May 3 and 4, be a part of the 2023 Breakthrough Summit. You'll get insight into why early-career life scientists are leaving academia at historic rates, hear what it will take for AI to truly change healthcare, learn how Verily is attempting to transform clinical trials, and more.

Unlock an agenda packed with groundbreaking content and engaging networking opportunities.  

Learn More

Featured Speakers:

  • Robert Nelsen, Co-Founder and Managing Director, ARCH Venture Partners
  • Thomas Insel, M.D., Executive Chair and Co-Founder, Vanna Health
  • Emily Whitehead, Co-Founder of the Emily Whitehead Foundation
  • Priti Krishtel, J.D., Co-Founder and Co-Executive Director, Initiative for Medicines, Access & Knowledge; 2022 MacArthur Fellow
  • Jennifer Doudna, Ph.D., Nobel Laureate, Co-inventor of CRISPR Technology; President, Innovative Genomics Institute
  • Stephen Gillett, Chief Executive Officer, Verily

Meet more speakers, explore the agenda, and find out more about virtual and in-person ticket options, at statnews.com/summit.


Questions?
Reach us at summit@statnews.com

23 Breakthrough Summit - Email Lock Up - 2823

Friday, March 31, 2023

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Place, Boston, MA 02109
©2023, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us

No comments